BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21771102)

  • 1. Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer.
    Berge V; Baco E; Dahl AA; Karlsen SJ
    Int J Urol; 2011 Sep; 18(9):646-51. PubMed ID: 21771102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
    Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
    Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage high-intensity focused ultrasound ablation for prostate cancer local recurrence after external-beam radiation therapy: prognostic value of prostate MRI.
    Rouvière O; Sbihi L; Gelet A; Chapelon JY
    Clin Radiol; 2013 Jul; 68(7):661-7. PubMed ID: 23485154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
    Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
    BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.
    Crouzet S; Murat FJ; Pommier P; Poissonnier L; Pasticier G; Rouviere O; Chapelon JY; Rabilloud M; Belot A; Mège-Lechevallier F; Tonoli-Catez H; Martin X; Gelet A
    Radiother Oncol; 2012 Nov; 105(2):198-202. PubMed ID: 23068708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
    Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
    BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
    Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
    Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the quality of life of patients suffering from localized prostate cancer treated with HIFU].
    Boudrant G; Mangin P; Feuillu B; Peiffert D; Cormier L
    Prog Urol; 2009 Sep; 19(8):542-52. PubMed ID: 19699452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results.
    Berge V; Baco E; Karlsen SJ
    Scand J Urol Nephrol; 2010 Sep; 44(4):223-7. PubMed ID: 20350272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.
    Baco E; Gelet A; Crouzet S; Rud E; Rouvière O; Tonoli-Catez H; Berge V; Chapelon JY; Eggesbø HB
    BJU Int; 2014 Oct; 114(4):532-40. PubMed ID: 24930692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study.
    Shoji S; Nakano M; Nagata Y; Usui Y; Terachi T; Uchida T
    Int J Urol; 2010 Aug; 17(8):715-9. PubMed ID: 20529139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.
    Kimura M; Mouraviev V; Tsivian M; Mayes JM; Satoh T; Polascik TJ
    BJU Int; 2010 Jan; 105(2):191-201. PubMed ID: 19583717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on: Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
    de la Rosette JJ
    Eur Urol; 2009 Mar; 55(3):647-8. PubMed ID: 18508190
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
    Cestari A; Guazzoni G
    Eur Urol; 2009 Mar; 55(3):648-9. PubMed ID: 18508189
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy.
    Namiki S; Saito S; Tochigi T; Ioritani N; Terai A; Arai Y
    Int J Urol; 2007 Mar; 14(3):186-91. PubMed ID: 17430252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
    Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
    BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
    Sanderson KM; Penson DF; Cai J; Groshen S; Stein JP; Lieskovsky G; Skinner DG
    J Urol; 2006 Nov; 176(5):2025-31; discussion 2031-2. PubMed ID: 17070244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A; Walter B; Rogenhofer S; Wieland WF
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
    Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
    BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.